The tetraspanin CD151 forms complexes in epithelial cell membranes with laminin-binding integrins a6b4, a3b1, and a6b1, and modifies integrin-mediated cell migration in vitro. We demonstrate in this study that CD151 expression is upregulated in a distinct temporal and spatial pattern during wound healing, particularly in the migrating epidermal tongue at the wound edge, suggesting a role for CD151 in keratinocyte migration. We show that healing is significantly impaired in CD151-null mice, with wounds gaping wider at 7 days post-injury. The rate of re-epithelialization of the CD151-null wounds is adversely affected, with significantly less wound area being covered by migrating epidermal cells. Our studies reveal that although laminin levels are similar in wildtype and CD151-null wounds, the organization of the laminin in the basement membrane is impaired. Furthermore, upregulation of a6 and b4 integrin expression is adversely affected in CD151-null mice wounds. In contrast, we find no significant effect of CD151 gene knockout on a3 and b1 integrin expression in wound repair. We suggest that mice lacking the CD151 gene are defective in wound healing, primarily owing to impairment of the re-epithelialization process. This may be due to defective basement membrane formation and epithelial cell adhesion and migration.
INTRODUCTION
The tetraspanins are a family of membrane proteins characterized by four transmembrane domains, one small and one large extracellular loop, short intracellular N-and C-terminal domains, and highly conserved cysteinecontaining motifs. Tetraspanins are expressed throughout phylogeny in multicellular organisms, indicating key roles in cell-cell communication and tissue organization. In mammals, there are approximately 30 different tetraspanins displaying 25-30% amino-acid identity mostly in the transmembrane domains. Most cell types express multiple tetraspanins, which associate with each other and with other membrane proteins giving rise to ''tetraspanin-enriched microdomains'' and modulating processes such as signal transduction and cell motility (Hemler, 2003; Wright et al., 2004a ).
An important group of tetraspanin-interacting proteins are the integrins, which mediate cell-matrix and cell-cell adhesion, cell survival, and migration. Integrins are heterodimeric cell membrane proteins that are widely expressed throughout mammalian tissues. In mammals, 18 different a chains and eight b chains, which can combine to give at least 24 integrin heterodimers with different ligand binding specificities, have been described (Hynes, 2002) . Integrins play key roles in epithelial function, as illustrated by the phenotypes of mice with targeted deletion of specific integrin genes. Four integrin chains, a3, a6, b1, and b4, have been shown to be particularly important for epidermal integrity. These chains combine to form heterodimers, a3b1, a6b1, and a6b4, which all bind to isoforms of laminin, a major component of the basement membrane. In particular, a6b4 is a component of hemidesmosomes, which are stable attachments linking the basement membrane to the keratin intermediate filaments (Jones et al., 1998a; Borradori and Sonnenberg, 1999) . Consistent with this, mice lacking the a6 or b4 integrin chain display a phenotype similar to the human disorder epidermolysis bullosa, characterized by detachment of the skin from the basement membrane, and die neonatally (Dowling et al., 1996; Georges-Labouesse et al., 1996; van der Neut et al., 1996) . Mice with deletion of the a3 integrin gene similarly die shortly after birth due to defects in kidney and lung epithelia and also display skin detachment due to rupture of the basement membrane (Kreidberg et al., 1996; DiPersio et al., 1997) . The b1 integrin chain forms heterodimers with many different a chains and its deletion in mice results in early embryonic lethality (Fassler and Meyer, 1995) . However, its function in skin has been studied by conditional knockout, and defects in epidermal proliferation, basement membrane formation, and hair follicle invagination have been observed (Brakebusch et al., 2000; Raghavan et al., 2000) . Epidermal wound healing in vivo of b1 integrin conditional knockout mice is retarded owing to impaired cell migration (Grose et al., 2002) .
The interactions of tetraspanins with b1 integrins and a6b4 integrin have been extensively characterized in vitro (Berditchevski, 2001) . Based on sensitivity to detergents of different strengths, the tetraspanin CD151 is believed to be the primary mediator of tetraspanin interactions with a3b1 and a6b1 integrins (Yauch et al., 1998 (Yauch et al., , 2000 Serru et al., 1999) . CD151 binds to the stalk region of the a3 integrin chain via a region of the large extracellular loop that is proximal to the fourth transmembrane domain and includes a critical QRD motif (Yauch et al., 2000; Berditchevski et al., 2001; Kazarov et al., 2002) . CD151 also associates strongly with the a6b4 complex , localizes to the basolateral surface of basal keratinocytes in human skin (Sincock et al., 1997) , and is a component of hemidesmosomes (Sterk et al., 2000; S. Fitter, R. Parton, and L. Ashman, unpublished data) . In less stringent detergents such as CHAPS, CD151 also co-immunoprecipitates other basement membrane-binding integrins including a4b1 and a5b1 integrins, which bind fibronectin (Hasegawa et al., 1998; Fitter et al., 1999; Sincock et al., 1999) . However, these associations have not been observed in some other studies (reviewed by Berditchevski, 2001) , possibly due to the complex-selective nature of some CD151 antibodies employed (Geary et al., 2001 ) and/or cell type-specific differences.
In contrast to mice lacking its core binding integrin partners, CD151-null mice are viable and healthy (Wright et al., 2004b) . They express a3 and a6 integrins normally, have morphologically normal hemidesmosomes, and do not display skin detachment. There is no evidence to date of abnormal kidney or lung function as observed in a3 integrinnull mice (Kreidberg et al., 1996) . CD151-null mice do, however, display abnormal keratinocyte migration in vitro, a mild bleeding disorder resulting from defective signalling via another CD151 interaction partner, integrin aIIbb3, as well as T-cell hyperproliferation of unknown mechanism (Lau et al., 2004; Wright et al., 2004b ). Interestingly, rare cases of lack of functional CD151 in humans results in restricted (pretibial) epidermolysis bullosa, with biopsy specimens displaying detachment of the epidermis from the dermis (Karamatic Crew et al., 2004) . These individuals also suffered renal failure, and electron microscopic examination of tissue from one patient revealed abnormalities of tubular and glomerular basement membranes.
Healing of epidermal wounds involves both proliferation and migration of keratinocytes as well as deposition of a provisional basement membrane rich in laminin 5, a ligand for a3b1 and a6b4 integrins (Goldfinger et al., 1999; Nguyen et al., 2000) . The process involves the coordinated action of growth factors produced in response to wounding, integrins, and matrix metalloproteases (Santoro and Gaudino, 2005) . We have now examined in vivo wound healing in CD151-null animals and found that it is significantly impaired compared with wild-type syngeneic mice. In wild-type mice, levels of a6 and b4 integrins, as well as CD151 itself, are markedly upregulated in wounds. This integrin upregulation is absent in CD151-null animals. Additionally, organization of laminin 5 appears to be impaired in CD151-null wounds, suggesting a function for CD151 in wound re-epithelialization and basement membrane formation.
RESULTS

CD151 is upregulated during normal wound healing
The temporal profile and cellular sources of CD151 expression during normal wound healing in wild-type C57BL/6 mice after full-thickness incisional wounding was assessed. Wounds were excised at 3, 7, and 14 days and revealed a distinct pattern of expression. In normal unwounded mouse skin, CD151 staining was observed predominantly in the basal keratinocytes ( Figure 1a ). Following wounding, CD151 . CD151 is upregulated in response to wounding. CD151 localizes to (a) basal keratinocytes in normal unwounded skin and (b) the tip of the migrating epidermis at 3 days post-wounding. (c) CD151 expression remains elevated throughout the epidermis at 7 days post-wounding (d) but by 14 days has returned to basal expression (n ¼ 10 per group). CD151-null wounds were also stained with CD151-specific antibody. (e) A 3-day null wound with no positive CD151 staining observed. In all images, e denotes the position of epidermis and w indicates the position of wound. The arrow in (a) points to positive staining in basal keratinocytes. Bar ¼ 50 mm (given in (e), but refers to all images). (f) Epidermal immunofluorescence intensity was quantified at 3, 7, and 14 days post-wounding in normal and wounded wild-type and CD151-null skin. *Po0.05 versus unwounded skin. Protein was extracted from unwounded (day 0) and wounded (day 7) skin from wild-type mice and CD151-null mice. A 10 mg portion was loaded per lane and analyzed by Western blotting using an antibody specific to CD151. (g) Blots were stripped and reprobed with an antibody specific to b-tubulin. (h) Densitometric quantitation of gels showing normalized CD151 protein levels in wild-type 7-day wounds. n ¼ 3; *Po0.05 versus unwounded skin.
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staining was upregulated and observed throughout the migrating epidermis at the wound edge 3 days post-wounding (Figure 1b and f) . CD151 staining persisted, although to a lesser extent, up to 7 days post-wounding (Figure 1c and f) until the wounds were full re-epithelialized but had returned to near basal levels by 14 days post-wounding (Figure 1d and f). Cellular staining of CD151 was also observed within newly forming granulation tissue within the wound in 3-and 7-day wounds (data not shown).
Consistent with the immunohistochemical pattern of increased wound staining intensity at days 3 and 7 declining at day 14 (Figure 1f ), CD151 protein levels, as measured by Western blotting, were significantly upregulated in response to wounding at 7 days (Figure 1g and h). The marked temporal upregulation of CD151 during early wound healing suggests a role for this protein in the re-epithelialization process.
Wound healing is impaired in CD151-null wounds
To determine directly the potential contribution of CD151 to wound healing, mice rendered null for the CD151 gene were used and their ability to heal full-thickness dorsal incisional wounds was compared with their wild-type counterparts. Healing was significantly impaired in CD151-null mice. Figure 2a and b shows representative wounds at day 7, with transverse sections shown in Figure 2c and d. The gape of the wounds was determined by measuring the width of the wounds at the midway point of the 1 cm incision at 0, 3, 7, and 14 days post-injury. Wound gape remained significantly elevated in the CD151-null mice 7 days post-wounding compared to the wild-type wounds ( Figure 2e) ; however, by 14 days, all the wounds had closed and no differences between wild-type and CD151-null mice wounds were observed macroscopically.
The distance between the wound margins was measured histologically at 3, 7, and 14 days post-wounding (Figure 2f ). Wounds were significantly larger at both 3 and 7 days postinjury, but by 14 days all the wounds had healed and no difference in wound size was observed. The distance between the dermal wound margins was also measured at 3, 7, and 14 days post-wounding as an indicator of the dermal wound healing component, and significantly increased dermal gape was observed in CD151-null mice wounds 7 days post-wounding (Figure 2g ).
Re-epithelialization is delayed in CD151-null wounds
Re-epithelialization of the wound site is a crucial part of the wound healing process. The percentage of the wound covered by epidermis was measured at 3, 7, and 14 days post-wounding and the results are shown in Figure 2h . (f) Wound sizes were significantly greater in CD151-null mice than in their wild-type counterparts at 3 and 7 days post-wounding. Results represent means7SEM (n ¼ 10 for each group; *Po0.05 vs wild type). Dermal wound gape was measured by measuring the distance between the dermal wound margins (arrows in a, b). (g) A significant increase in dermal gape was observed at 7 days in CD151-null mice. Results represent means7SEM (n ¼ 10 for each group; *Po0.05). (h) Wound re-epithelialization was evaluated by measuring the percentage of the wound that had epidermal covering at days 3, 7, and 14. A significant decrease in re-epithelialization was observed at day 7 in CD151-null mice. Results represent means7SEM (n ¼ 10 for each group; *Po0.05).
Re-epithelialization was impaired in CD151-null wounds at 3 and 7 days post-wounding with about 20% decrease in reepithelialization occurring at 7 days (Figure 2h ), indicating a potential function for CD151 in epidermal migration and adhesion. The number of proliferating keratinocytes in the epidermis at the edge of the wound and migrating across the wound surface was also determined using the proliferating cell nuclear antigen (PCNA) marker. Significantly fewer PCNA-positive cells were observed in the epidermis of 3-day CD151-null wounds compared to their wild-type counterparts (Figure 3a -c). However, by 7 days, no difference in keratinocyte proliferation between CD151-null or wildtype wounds was observed ( Figure 3c ).
Laminin organization is impaired in CD151-null wounds
The formation of a new basement membrane is a key step in the re-epithelialization process. To characterize the effect of CD151 on deposition of the basement membrane, CD151-null and wild-type wounds were analyzed for laminin 5, a protein that localizes predominantly to the basement membrane in skin (Goldfinger et al., 1999; Nguyen et al., 2000) . In normal, unwounded skin from wild-type mice, laminin 5 expression was observed predominantly at the basement membrane ( Figure 4a ). In contrast, normal skin from CD151-null mice showed little laminin 5 staining at the basement membrane ( Figure 4b ). Laminin 5 expression was increased, relative to adjacent normal tissue, at the wound edge 3 days post-wounding (Figure 4c ), and this elevation persisted up to 7 days post-wounding ( Figure 4e ). The staining was observed as a sharp band underneath the basal keratinocytes in wounds of wild-type mice (Figure 4a and c). By contrast, in wounds of CD151-null mice, although laminin 5 levels were increased in response to wounding (Figure 4d and f), the localization of the protein was different. Laminin 5 was not restricted to the basal site of the keratinocytes, but looked dispersed and stained a more extended area within the migrating epidermis. Western blotting did not reveal a significant increase in laminin 5 subunit expression in 7-day wounds in wild-type mice compared to CD151-null mice (Figure 4g and h). This staining pattern was obtained with two independent laminin 5 antibodies. Therefore, it would appear that the tetraspanin CD151 is not required for laminin 5 production, but is necessary for its organization and deposition in the basement membrane. Bar ¼ 50 mm (given in (f), but refers to all images). n ¼ 10 for each group. Arrows in (a, c, e) point to positive staining of basement membrane, which is not observed in (b, d, f) . In all images, e denotes the position of epidermis and w indicates the position of wound. Protein was extracted from unwounded (day 0) and wounded (day 7) skin from wild-type mice and CD151-null mice. A 10 mg portion was loaded per lane and analyzed by Western blotting using an antibody specific to laminin 5. (g) Blots were stripped and reprobed with an antibody specific to b-tubulin. (h) Densitometric quantitation of gels showing normalized laminin 5 protein levels in wild-type 7-day wounds. n ¼ 3.
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Wound Healing in CD151 Null Mice
Altered expression of a6 and b4 integrins in CD151-null wounds
Immunostaining using an integrin a6-specific antibody revealed increased a6 immunostaining in response to wounding in wild-type mice wounds (Figure 5a , c, and e). This was particularly intense at the tip of the migrating epidermal tongue (Figure 5c ). Integrin a6 was observed primarily staining basal keratinocytes attached to the basement membrane. Increased staining was observed in response to wounding, peaking at 3 days in wild-type wounds, remaining elevated until the wounds were completely re-epithelialized at 7 days (Figure 5e ), and returning to basal levels by 14 days. In marked contrast, in CD151-null wounds, a6 integrin expression at 3 days post-wounding was very low and barely detectable at 7 days (Figure 5d and f).
Western blotting also revealed a significant increase in a6 integrin protein expression 7 days post-wounding in wildtype mice; however, no increase in a6 expression was observed in CD151-null wounds (Figure 5g and h). Integrin b4 is found on the cell surface as a heterodimeric complex with a6. This a6b4 integrin complex, which associates with CD151, is a receptor for laminin 5 and has a role in basement membrane adhesion. Therefore, the effect of CD151 gene deletion on b4 integrin was also investigated. Immunostaining using a b4 integrin-specific antibody showed specific staining along the basement membrane in normal unwounded skin of wild-type mice (Figure 6a) . No staining along the basement membrane was observed in CD151-null unwounded skin (Figure 6b ). Upregulation of b4 integrin expression was observed in response to wounding in normal wild-type wounds at 3 and 7 days post-injury (Figure 6c and e). Increased staining for b4 integrin was observed along the basement membrane, particularly at the wound edge where a marked increase in expression was observed 3 days postwounding (Figure 6c ). b4 integrin remained elevated in wildtype wounds at 7 days post-wounding (Figure 6e) , with continuous positive staining of the basement membrane and basal keratinocytes. In CD151-null wounds, b4 integrinpositive staining was observed; however, the staining was not restricted to the basement membrane but haphazard within the basal keratinocytes (Figure 6d ) By 7 days, staining of the basement membrane was observed but this was not continuous and gaps could be seen (arrows in Figure 6f) . Consistent with the immunhistochemical staining, Western blotting also revealed a significant increase in b4 integrin protein expression 7 days post-wounding in wild-type mice but not in CD151-null wounds (Figure 6g and h) .
Integrin a3 expression in CD151-null wounds Integrin a3 expression increased in response to wounding in wild-type and CD151-null wounds (Figure 7a-d) . This expression was throughout the migrating tip of the epidermis, with basal and suprabasal keratinocyte staining observed. This may suggest a mechanism by which the CD151-null wounds were able to re-epithelialize their wounds, albeit significantly slower than their wild-type counterparts. Immunofluorescent quantification of a3 expression in day-3 wounds showed increased a3 expression, although the results were not statistically significant. Western blotting of protein extracted from the wild-type and CD151-null wounds supported the immunostaining data, showing increased a3 expression in response to wounding (Figure 7g and h) .
Integrin b1 or a1 expression in CD151-null wounds Integrin b1 is expressed on the cell surface as a heterodimer with integrin a1 through to a11 and av. Expression of integrin b1 was induced in response to wounding in both wild-type and CD151-null wounds. Although the staining was predominantly in the basal keratinocytes, suprabasal cell staining was also observed along the newly forming epidermis from the wound margin to the migrating epidermal tip at 3 and 7 days post-wounding (Figure 7g and h). By 14 days, when the wounds were completely re-epithelialized, b1 staining had returned to basal levels. No differences were observed in either the localization or the intensity of staining between wild-type and CD151-null wounds. Western blotting showed no significant effect of CD151-null mutation on b1 protein levels (Figure 7e and h). No differences in a1 staining either in tissue localization or intensity were observed between wild-type and CD151-null wounds at 3, 7, or 14 days post-injury (data not shown).
DISCUSSION
Epidermal wound healing is a tightly regulated process involving proliferation and migration of keratinocytes at the wound margins and deposition of a provisional matrix on the wound bed. Laminin 5 and its integrin receptors, a3b1 and a6b4, have been reported to play a central role in this process (Goldfinger et al., 1999; Nguyen et al., 2000; Santoro and Gaudino, 2005) . These laminin-binding integrins form strong complexes with the tetraspanin CD151, affecting integrin signalling (reviewed by Berditchevski, 2001; Hemler, 2003) . Although the skin of mice with targeted deletion of CD151 is morphologically normal, we previously demonstrated defective outgrowth of keratinocytes from neonatal skin explants from these mice in vitro, a surrogate assay for epidermal wound healing (Wright et al., 2004b) . We have now examined the role of CD151 in epidermal wound healing in vivo.
Here, we demonstrate that CD151 is expressed in a distinct spatial and temporal profile during murine wound healing. Upregulation of CD151 expression was observed in both the basal and suprabasal keratinocytes of the migrating epidermis and in wound tissue from wild-type mice (Figure 1 ), pointing to CD151 having an important role in the reepithelialization process. The functional role of CD151 in wound healing was demonstrated by retarded re-epithelialization and wound closure in CD151-null mice. In these mice, healing was delayed, with wounds being significantly larger 7 days post-wounding (Figure 2 ), suggesting that CD151 may be an integral component of the healing response. Wounds in CD151-null mice also had a significantly slower rate of re-epithelialization and reduced keratinocyte proliferation, indicating impaired ability of the keratinocytes to proliferate and migrate across the wound bed. Our data are the first to show a functional effect of CD151 knockdown in epidermal wound healing in vivo.
During wound healing, two processes have to occur: the migration of cells to ensure that a wound site is covered and, at the same time, stabilization of epithelial-wound bed interactions. Previous studies with inhibitory antibodies, or overexpression in vitro, have established the importance of tetraspanins, including CD151, in cell migration (Boucheix and Rubinstein, 2001; Yanez-Mo et al., 2001) . For example, Penas et al. (2000) showed that human keratinocyte migration in vitro can be inhibited using anti-CD151 monoclonal antibodies. Both migration and stabilization of keratinocyte-wound bed interactions involve binding of cell surface integrins to newly deposited extracellular matrix. Deposition of laminin-5 in wounded skin is essential for proper adhesion and migration of keratinocytes (Goldfinger et al., 1998) . During migration, keratinocytes initially deposit large amounts of laminin 5 precursor in the matrix. A tightly regulated stepwise processing of laminin-5 modulates the affinity to different integrin receptors and thereby is essential to maintain the balance between adhesion and motility that is required for controlled migration (reviewed by Nguyen et al., 2000) . Specifically, unprocessed laminin-5 preferentially binds a3b1, which is pro-migratory. In addition, ligation of a3b1 is required for processing and organization of laminin-5 in the extracellular matrix (deHart et al., 2003) . Subsequently, www.jidonline.org 685 processed laminin-5 preferentially binds to a6b4 integrin, stabilizing cell-substrate interaction. In epithelial cells, the laminin-5-a6b4 complex induces the formation of hemidesmosomes, which enforce the attachment of basal cells to the basement membrane in stratified epithelium (Jones et al., 1998b; Sterk et al., 2000) . In the context of wound healing, the laminin-5-a6b4 complex may lead to the assembly of immature hemidesmosomes, which may be more dynamic than their mature counterparts allowing cell migration to occur while also providing stability for cell-wound bed interactions (Tsuruta et al., 2003) . Thus, an appropriately organized laminin-5 extracellular matrix is required for both keratinocyte migration into the wound and stabilization of cell-substrate interaction (Goldfinger et al., 1999) . As CD151 regulates the functions of both a3 and a6 integrins, which are the major laminin-5-binding integrins, we examined the deposition of laminin-5 in epidermal wounds in both null and wild-type mice. In addition to delayed re-epithelialization, formation of the basement membrane was also affected in CD151-null wounds. Analysis of the 7-day wounds of CD151-null mice revealed significant abnormalities in the deposition of newly synthesized laminin-5. No discrete band of laminin-5 staining was observed in the migrating epithelium at the wound edge, as was observed in corresponding wild-type wounds. The staining pattern was more diffuse and disorganized, with laminin-5 staining observed throughout the epidermis at the wound edge (Figure 3) . The data suggest that CD151 is required for correct organization of laminin-5 in wounds, contributing to delayed wound healing in CD151-null mice.
We went on to examine the levels and organization of a3, a6, b1, and b4 integrin chains in wound tissue. Several b1 integrins are potentially important in this system, notably the collagen receptor a2b1, the fibronectin receptors a5b1 and a9b1, and the laminin receptors a3b1 and a6b1 (reviewed by Nguyen et al., 2000; Singh et al., 2004) . However, a3b1 and a6b1, together with a6b4, are the predominant binding partners of CD151 in epithelial cells. As previously reported for isolated keratinocytes (Wright et al., 2004b) , expression of these integrins was normal in the unwounded skin of CD151-null mice (Figures 4 and 5) . In epidermal wounds in wild-type mice, similar to previous reports (Hertle et al., 1992) , b1 integrin was upregulated along the migrating edge of the epithelium, and although expression was observed primarily in the basal keratinocytes, suprabasal expression was observed in response to wounding. Similarly, in CD151-null wounds, b1 integrin expression was observed in the basal and suprabasal keratinocytes and was upregulated along the migrating epidermis, although total levels of b1 did not change ( Figure 5 ). Suprabasal expression of a3 integrin was also observed in wounds, similar to previous wound healing studies (Clark 1990; Hertle et al., 1992) . There was however No difference in b1 staining was observed between wild-type and CD151-null wounds. n ¼ 6 for each group. Bar ¼ 50 mm (given in (h), but refers to all images). In all images, e denotes the position of epidermis and w indicates the position of wound. Protein was extracted from unwounded (day 0) and wounded (day 7) skin from wild-type and CD151-null mice. A 10 mg portion was loaded per lane and analyzed by Western blotting using antibodies specific to integrins a3 and b1. (j) Blots were stripped and reprobed with an antibody to b-tubulin. n ¼ 3 for each group. (k, l) Normalized densitometric quantification. no significant alteration in the distribution or total amount of a3 integrin in CD151-null mice relative to wild-type mice. The function of b1 integrins in epidermal wound healing has been studied using conditional knockouts where b1 gene deletion was restricted to keratinocytes. Delayed wound healing due to impaired keratinocyte migration was also observed in those animals (Grose et al., 2002) . Although our data suggest that the wound healing defect in CD151-null mice was not attributable to altered expression or localization of b1 integrins, these integrins likely contributed to the reepithelialization of the wounds, which did occur in CD151-null mice, albeit more slowly than in normal mice. Furthermore, integrin a3-null mice display abnormal basement membrane architecture and function (DiPersio et al., 1997) , and studies with keratinocytes from these mice have shown that a3b1 plays a key role in the organization of laminin-5 in the extracellular matrix in vitro (deHart et al., 2003) . As CD151 modulates outside-in signalling via a3b1 and other integrins (Sawada et al., 2003; Lau et al., 2004) , it remains possible that disorganization of the laminin-5 extracellular matrix in CD151-null mice may arise from altered signalling via a3b1, even though expression of this integrin was not significantly altered.
In contrast to the results with a3 and b1 integrin chains, abnormal expression of the integrins a6 and b4 was observed in wounds in CD151-null mice. In wild-type mice, expression of these integrins was significantly increased in the migrating epidermis at 3 days post-wounding and in the newly formed epidermis 7 days post-injury, similar to that previously reported (Larjava et al., 1993; Nguyen et al., 2000) . However, in CD151-null wounds, no upregulation of either a6 or b4 expression was observed, either by immunofluorescence microscopy or Western blotting. Although a6 and b4 expression was observed in CD151-null wounds, the staining pattern was haphazard and disorganized ( Figure 4) . Consistent with studies by Russell et al. (2003) , our data suggest that the failure to upregulate and correctly organize expression of a6b4 integrin plays a central role in defective wound healing in CD151-null mice.
In summary, our studies have revealed a functional role for CD151 in epidermal wound healing. In wild-type mice, CD151 protein expression levels were upregulated in wounds, suggesting a functional role in healing. Consistent with this, the gene knockout of CD151 resulted in impaired healing and delayed re-epithelialization. Organization of laminin-5 extracellular matrix was defective, and upregulation of integrins a6 and b4 in the wounds was prevented in the absence of CD151. The impaired deposition of laminin-5 and failure to upregulate expression of a6b4 may result in an altered balance between the different types of adhesion structures in CD151-null wounds, and may explain why wound healing is retarded in CD151-null mice.
MATERIALS AND METHODS
Antibodies
Rabbit anti-CD151 (sc-18753) was obtained from Santa Cruz (Santa Cruz, CA) and is an antibody raised against a peptide mapping near the amino terminus of human CD151. Integrin a1 (sc-6596) and a6 (sc-6596) were obtained from Santa Cruz (Santa Cruz, CA), and are antibodies raised against epitopes corresponding to an amino-acid sequence mapping at the carboxy terminus of the precursor form of integrin a1 and a6, respectively. Rabbit polyclonal anti-human integrin a3 was a kind gift from Fedor Berditchevski (Cancer Research UK, University of Birmingham, Birmingham, UK). The antibody was raised against the cytoplasmic tail of human a3 integrin, but crossreacts with mouse a3. Monoclonal rat anti-mouse integrin b4 was obtained from PharMingen (North Ryde, Australia (346-11A) ). This antibody reacts with an epitope at the beginning of the cysteine-rich repeat region of the 200 kDa b 4 integrin chain. The monoclonal antibody rat anti-mouse integrin b1 (9EG7) was from PharMingen and this antibody reacts with the 130 kDa integrin b1 chain (CD29). Laminin 5 (J18) polyclonal antiserum was raised in rabbit using rat laminin 5 purified from extracellular matrix preparations of 804G cells, as previously described (Langhofer et al., 1993) . Mouse anti-PCNA was obtained from Sigma-Aldrich (Sydney, Australia).
Generation of CD151-null mice
The construction of CD151-null mice on a C57BL/6 background has been recently described (Wright et al., 2004b) . These and normal syngeneic mice were bred at the Central Animal House, University of Newcastle, and were then housed in a specific-pathogen-free facility at the Women's and Children's Hospital Animal House Facility for the duration of the experiments.
Animal studies
All experiments were approved by the Adelaide Women's and Children's Hospital Animal Care and Ethics Committee following the Australian Code of Practice for the Care and the Use of Animals for Scientific Purposes.
Murine surgical techniques
Wild-type and CD151-null male mice (16-20 weeks old) were anesthetized with inhaled isofluorane, and the dorsum shaved and cleaned with 10% w/v povidine iodine solution. Two equidistant 1 cm full-thickness incisions were made through the skin and panniculus carnosus using fine scissors on the flanks of the animals extending 3.5-4.5 cm from the base of the skull, 1 cm on either side of the spinal column. The wounds were left to heal by secondary intention (i.e., the wound edges were not closed by sutures). Digital photographs were taken of the wounds at 0, 3, 7, and 14 days postwounding. A ruler was aligned next to the wound to allow direct wound area and wound gape (midpoint of the 1 cm incision) measurements to be made. Wounds were harvested at 3, 7, and 14 days and were bisected. One half was fixed in 10% buffered formalin and processed so that the midpoint of the wound was sectioned and compared between groups. The other half was microdissected to remove any contaminating normal, unwounded skin and snap-frozen in liquid nitrogen for protein extraction and Western blot analysis.
Histology, immunohistochemistry, and image analysis
Histological sections were prepared from wound tissue fixed in 10% buffered formalin and embedded in paraffin. Four-micrometer sections were cut and floated onto Snowcoat TM slides (Surgipath, Richmond, IL), baked overnight at 551C, and stored at room www.jidonline.org 687 temperature. Sections were stained with hematoxylin and eosin or subjected to immunohistochemistry following antigen retrieval as follows.
The sections were deparaffinized in xylene for 10 minutes and rehydrated through a series of decreasing ethanol dilutions. Sections were placed in a target retrieval solution (DAKO Corporation, Botany, Australia), boiled for 2 minutes initially in a 900 W microwave, and then heated on medium power for 2 Â 5 minutes before being rapidly cooled to 501C on ice. The sections were washed in phosphate-buffered saline (PBS) before incubation with 0.025% trypsin at 371C for 3 minutes. After further PBS washes, the sections were blocked in 3% normal horse serum for 30 minutes. Primary antibodies a1, a6, b1, b4, and CD151 were applied at a 1:100 dilution and Laminin-5 at 1:200 and slides were incubated at 41C overnight in a humidified chamber. Slides were rinsed three times in PBS and incubated for 1 hour at room temperature with species-specific biotinylated secondary antibodies (1:200). Slides were rinsed with 2-3 washes of PBS before final incubation of CY3-conjugated streptavidin (Sigma-Aldrich, Sydney, Australia) 1:200 dilution in PBS was applied for 40 minutes at room temperature. The stained sections were finally mounted in Dako fluorescent mounting medium (DAKO Corporation, Botany, Australia) and analysis of immunofluorescence was determined using AnalySIS software package (Soft Imaging System GmbH, Munster, Germany). For verification of staining, negative controls included replacement of the primary antibodies by either normal rabbit IgG (laminin), normal mouse (b1, b4), or normal goat IgG (a1, a6). On additional control sections, the primary and secondary antibodies were left out to determine nonspecific binding. All control sections had negligible immunofluorescence.
Kertinocyte proliferation was determined using the PCNA immunostaining technique (Geier et al., 2005) . PCNA-positive cells were counted and expressed as a percentage of total keratinocytes in the migrating epithelial tongue at the wound edge.
Histological image analysis
Image analysis was performed using ImageProPlus program (MediaCybernetics Inc., Silver Spring, MD). Wound size was determined by manually drawing below the epidermis or clot between the wound margins (which can easily be seen where thick collagen bundles appear as representative of intact skin). The percentage of the wound that has re-epithelialized was determined by measuring the portion of the wound that was covered with epidermis as a percentage of the entire wound. Dermal gape was determined by drawing between the dermal wound margins. Blinded scoring of histological slides by two independent assessors was undertaken.
Western blotting
Protein was extracted from wild-type and CD151-null mouse wounds using standard protein extraction protocols. Briefly, wound tissue was microdissected to remove normal, unwounded skin, chopped and placed in lysis buffer (50 mM Tris pH 7.5, 1 mM EDTA, 50 mM NaCl, 0.5% Triton X-100, containing protease inhibitor cocktail tablet (1 per 10 ml; Complete, Mini (Roche Products Pty Ltd, Dee Why, NSW, Australia)) and the samples were homogenized briefly. Samples were centrifuged (16,000 Â g, 10 minutes, at 41C), with supernatants being transferred to fresh tubes and centrifuged for a further 10 minutes and the supernatants stored at À201C. Sample proteins (10 mg) were run on 12.5% SDS-PAGE gels at 100 V for 1 hour and then transferred to nitrocellulose by semidry transfer (BioRad Laboratories, Regents Park, NSW, Australia) at 5 V for 1 hour. The membranes were stained with Poinceau Red to ensure even loading of the gels with protein. Membranes were blocked in 15% milk blocking buffer for 10 minutes and primary antibodies added in PBS containing 3% skimmed milk powder in PBS/0.3% Tween for 1 hour at room temperature. After two washes in PBS containing 3% skimmed milk powder/0.3% Tween, appropriate species-specific secondary horseradish peroxidase-conjugated antibodies were added for a further 1 hour at room temperature. Stringent washes for 1 hour were then performed before detection of horseradish peroxidase by enhanced chemiluminescence reagent (Amersham Biosciences UK Limited, Buckinghamshire, UK) and exposure to X-ray film. Membranes were stripped and reprobed for b-tubulin (Sigma-Aldrich, Sydney, Australia) for normalization of protein levels. Densitometric analysis of the resulting bands was performed using Image J software (NIH).
Statistical analysis. Statistical differences were determined using the t-test or an analysis of variance. For data not following a normal distribution, the Mann-Whitney U-test was used. A P-value of less than 0.05 was considered significant.
